Published in Hum Reprod on January 18, 2009
Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. Lancet Oncol (2013) 2.16
Current achievements and future research directions in ovarian tissue culture, in vitro follicle development and transplantation: implications for fertility preservation. Hum Reprod Update (2010) 1.89
Impact of cancer therapies on ovarian reserve. Fertil Steril (2011) 1.28
Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency. Nat Rev Endocrinol (2012) 1.24
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer. Eur J Cancer (2013) 0.97
Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications. J Clin Oncol (2013) 0.96
A changing perspective: improving access to fertility preservation. Nat Rev Clin Oncol (2010) 0.94
The Gynecologist Has a Unique Role in Providing Oncofertility Care to Young Cancer Patients. US Obstet Gynecol (2011) 0.93
Incorporating fertility preservation into the care of young oncology patients. Cancer (2011) 0.90
Pregnancy after cancer: results from a prospective cohort study of cancer survivors. Pediatr Blood Cancer (2013) 0.86
Contraception for cancer survivors. J Gen Intern Med (2009) 0.85
Long-term nephrotoxicity in adult survivors of childhood cancer. Clin J Am Soc Nephrol (2013) 0.83
Anti-müllerian hormone as a sensitive marker of ovarian function in young cancer survivors. Int J Endocrinol (2013) 0.82
Assessment of ovarian function after preparative chemotherapy and total body radiation for adoptive cell therapy. J Immunother (2011) 0.82
Endocrinopathies in survivors of childhood neoplasia. Front Pediatr (2014) 0.76
Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood. BMC Pediatr (2011) 0.76
Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma. J Clin Diagn Res (2016) 0.76
Changes in plasma müllerian-inhibiting substance and brain-derived neurotrophic factor after chemotherapy in premenopausal women. Fertil Steril (2011) 0.76
Anti-Müllerian Hormone Levels and Urinary Cortisol in Women With Chronic Abdominal Pain. J Obstet Gynecol Neonatal Nurs (2016) 0.75
Chemotherapy-induced damage to ovary: mechanisms and clinical impact. Future Oncol (2016) 0.75
New insights to the MLL recombinome of acute leukemias. Leukemia (2009) 4.07
Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod (2002) 3.59
[Cushing's syndrome. I. New diagnostic developments]. Ned Tijdschr Geneeskd (2006) 2.73
The MLL recombinome of acute leukemias in 2013. Leukemia (2013) 2.55
Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology (1999) 2.42
Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. J Clin Endocrinol Metab (2000) 2.36
Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology (2001) 2.28
Anti-mullerian hormone predicts menopause: a long-term follow-up study in normoovulatory women. J Clin Endocrinol Metab (2011) 2.02
The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancer. Hum Reprod (2006) 1.93
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort. Hum Reprod (2011) 1.80
Cortisol receptor resistance: the variability of its clinical presentation and response to treatment. J Clin Endocrinol Metab (1992) 1.72
Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance. Hum Genet (1997) 1.66
Adrenal glands of mouse and rat do not synthesize androgens. Life Sci (1992) 1.64
A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update (2005) 1.63
Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab (2008) 1.60
Drug-induced ciliary body oedema: a new theory. Eye (Lond) (1996) 1.57
Development of a sensitive enzyme immunoassay for anti-Müllerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) (2005) 1.57
Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. Eur J Endocrinol (1998) 1.51
The endocrine and follicular growth dynamics throughout the menstrual cycle in women with consistently or variably elevated early follicular phase FSH compared with controls. Hum Reprod (2008) 1.46
Haemodynamic and neurohumoral effects of xenon anaesthesia. A comparison with nitrous oxide. Anaesthesia (1990) 1.44
Relationship between ovarian production of estrone, estradiol, testosterone, and androstenedione and the ovarian degree of stromal hyperplasia in postmenopausal women. Menopause (1998) 1.43
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. J Assist Reprod Genet (2005) 1.42
Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. Clin Endocrinol (Oxf) (1997) 1.41
'Pseudo-aldosteronism' induced by intravenous glycyrrhizin treatment of chronic hepatitis C patients. J Gastroenterol Hepatol (2001) 1.41
Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab (1984) 1.39
Long-term remission after non-radical surgery combined with brachytherapy in an infant with a chemo-resistant rhabdomyosarcoma of the tongue. Med Pediatr Oncol (2003) 1.39
Cushing syndrome as a presenting symptom of renal tumors in children. Pediatr Blood Cancer (2009) 1.39
Corticosteroid therapy in severe illness. N Engl J Med (1997) 1.38
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod (2006) 1.35
Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab (2012) 1.35
Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. J Clin Endocrinol Metab (1998) 1.33
Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology (2008) 1.31
Differential coreceptor expression allows for independent evolution of non-syncytium-inducing and syncytium-inducing HIV-1. J Clin Invest (2000) 1.29
Evaluation of a radioimmunoassay for testosterone estimation. J Steroid Biochem (1973) 1.23
Anti-Müllerian hormone: a marker for oocyte quantity, oocyte quality and embryo quality? Reprod Biomed Online (2008) 1.21
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer. Lancet (1982) 1.20
Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab (2008) 1.18
Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML. Leukemia (2008) 1.18
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia (2013) 1.16
17Beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab (1999) 1.16
Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod (2009) 1.15
A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair. J Clin Endocrinol Metab (2012) 1.14
Clear cell sarcoma of the kidney: a review. Eur J Cancer (2012) 1.14
Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study Group. Eur J Cancer (2013) 1.12
Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies. Hum Reprod (2008) 1.10
Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod (2010) 1.09
Components of the metabolic syndrome in 500 adult long-term survivors of childhood cancer. Ann Oncol (2009) 1.08
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Leukemia (2010) 1.07
Growth patterns of nondominant ovarian follicles during the normal menstrual cycle. Fertil Steril (1990) 1.07
Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups. Leukemia (2011) 1.07
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations. Leukemia (2012) 1.06
Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol (2010) 1.06
11beta-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation. Mol Endocrinol (2004) 1.05
A randomized trial investigating an exercise program to prevent reduction of bone mineral density and impairment of motor performance during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer (2009) 1.05
A prospective study on cortisol, dehydroepiandrosterone sulfate, and cognitive function in the elderly. J Clin Endocrinol Metab (1998) 1.04
Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther (1987) 1.03
Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. Med Pediatr Oncol (2000) 1.03
Melatonin and melatonin-progestin combinations alter pituitary-ovarian function in women and can inhibit ovulation. J Clin Endocrinol Metab (1992) 1.03
Phototherapeutic keratectomy for bullous keratopathy. Br J Ophthalmol (1995) 1.02
Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine (2005) 1.01
[Ocular barostress and barotrauma. A study of 15 scuba divers]. Klin Monbl Augenheilkd (2001) 1.01
Effect of gonadotrophins on the secretion of oestradiol- and testosterone by the rat testis. J Endocrinol (1973) 1.01
Plasma oestradiol-17beta and its relationship to serum follicle-stimulating hormone in immature female rats. J Endocrinol (1973) 1.01
Inhibin: 1985 update on action and purification. Mol Cell Endocrinol (1985) 1.01
Low frequency of DNMT3A mutations in pediatric AML, and the identification of the OCI-AML3 cell line as an in vitro model. Leukemia (2011) 1.01
Fluconazole inhibits human adrenocortical steroidogenesis in vitro. J Endocrinol (2012) 1.00
TET2 mutations in childhood leukemia. Leukemia (2010) 0.99
Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril (1995) 0.99
[Perioperative circulatory side effects of topical 5% phenylephrine for mydriasis]. Klin Monbl Augenheilkd (1999) 0.99
Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor gene. J Clin Endocrinol Metab (2000) 0.99
Differential hormone-dependent transcriptional activation and -repression by naturally occurring human glucocorticoid receptor variants. Mol Endocrinol (1997) 0.98
The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML). Leukemia (2004) 0.98
Combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in the capsular bag: a comparison to vitrectomy and subsequent cataract surgery as a two-step procedure. Ophthalmic Surg Lasers (1996) 0.98
Long-term effects of buserelin on plasma testosterone and luteinising hormone concentrations. Lancet (1985) 0.97
[Results of in vitro fertilization in the Netherlands, 1996-2000]. Ned Tijdschr Geneeskd (2002) 0.97
The preconception diet is associated with the chance of ongoing pregnancy in women undergoing IVF/ICSI treatment. Hum Reprod (2012) 0.97
Castration-induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice. Prostate (1993) 0.97
Gain of 1q is a marker of poor prognosis in Wilms' tumors. Genes Chromosomes Cancer (2013) 0.97
The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review. Eur J Endocrinol (2013) 0.97